Brokers Offer Predictions for Xeris Biopharma Q1 Earnings
Xeris Biopharma Holdings, Inc. (NASDAQ:XERS – Free Report) – Equities research analysts at HC Wainwright issued their Q1 2025 earnings estimates for Xeris Biopharma in a research report issued on Friday, March 7th. HC Wainwright analyst O. Livnat anticipates that the company will post earnings of ($0.08) per share for the quarter. HC Wainwright currently […]
